Fig. 5. Increased expression of SLC6A12 was associated with a high risk of death in ovarian cancer patients. Forest plot of the significant association between increased risk of death and high expression of SLC6A12 in 1979 serous-type ovarian cancer patients from 13 independent studies found in curatedOvarianData. SLC6A12, solute carrier family 6, member 12.
